News

Vitalant Research Institute (VRI) is helping direct collection and processing of blood plasma donations from recovered COVID-19 patients and developing technologies to detect and quantify virus-fighting antibodies.

March 23, 2020 — Coronavirus responses have significantly impacted the U.S. blood supply as Vitalant and other blood centers across the country cope with stabilizing blood inventories to meet patients’ transfusion needs.

March 9, 2020 – Amidst novel coronavirus (COVID-19) prevention measures, Vitalant and other blood centers nationwide are urging healthy individuals to donate blood—and organizations to maintain scheduled blood drives—to ensure patients have the lifesaving blood they need.

Blood Systems announced Sept. 24, 2018 that its 10 blood center brands, research institute and specialty laboratory will unite as Vitalant.